Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The V118I mutation as a marker of advanced HIV infection and disease progression.

Antiviral therapy - 1 Jan 2007

Zaccarelli Mauro, Tozzi Valerio, Lorenzini Patrizia, Forbici Federica, Narciso Pasquale, Ceccherini-Silberstein Francesca, Trotta Maria Paola, Bertoli Ada, Liuzzi Giuseppina, Marconi Patrizia, Mosti Silvia, Perno Carlo Federico, Antinori Andrea

Abstract excerpt

BACKGROUND: The V118I mutation is included in the nucleoside analogue mutations (NAMs) set. It contributes to thymidine-analogue resistance and, consequently, to resistance to the whole nucleoside reverse transcriptase inhibitor (NRTI) class. We focused on the V1181 mutation in order to evaluate factors associated with its detection and its relationship with HIV progression. METHODS: Clinical and laboratory data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Lymphocyte Count
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Reverse Transcriptase

Share to Isoleucine

Share to Proportional Hazards Models

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Share to Valine

Source

Identifiers

PMID: 17503658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The V118I mutation as a marker of advanced HIV infection and disease progression.PMID 17503658Read ↗

Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy.Semantic proximity Read ↗

Update of the Drug Resistance Mutations in HIV-1: December 2010Semantic proximity Read ↗

Differential Effects of the G118R, H51Y, and E138K Resistance Substitutions in Different Subtypes of HIV IntegraseSemantic proximity Read ↗

Update of the drug resistance mutations in HIV-1: December 2010.Semantic proximity Read ↗

Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.Semantic proximity Read ↗

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitorsSemantic proximity Read ↗

The reverse transcriptase (RT) mutation V118I is associated with virologic failure on abacavir-based antiretroviral treatment (ART) in HIV-1 infection.Semantic proximity Read ↗

N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.Semantic proximity Read ↗

Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon.Semantic proximity Read ↗

Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.Semantic proximity Read ↗

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.